Bruce Labe Gewertz MD

Prior to joining Cedars-Sinai, Dr. Gewertz served on the faculty at the University of Chicago (1981-2006). There he enjoyed a regional and national referral practice in vascular surgery and established a fully funded laboratory focused on cellular mechanisms of ischemia-reperfusion injury. In his very substantial body of basic science work, Dr. Gewertz was consistently funded by the NIH and American Heart Association and published his work in the most highly refereed research journals such as the American Journal of Physiology and Arteriosclerosis Thrombosis and Vascular Biology. In specific, he characterized the patterns of autoregulation of blood flow in the heart, kidney, and intestine. He developed a unique model of ex vivo perfusion of rat and then human intestine that added fundamental knowledge of the role of reactive oxygen specifies in the intracellular signaling during ischemia-reperfusion injury.

For the last 14 years of his tenure at the University of Chicago, he served as the Dallas Phemister Professor and Chair of the Department of Surgery. The Department included all surgical disciplines and more than doubled in size and revenues during his chairmanship. Federal funding was also substantially increased (> 3 fold) to consistently place the department in the top 20 surgery units in the country.

Since joining Cedars-Sinai Health System in 2006, he has focused on ensuring that hospital operations support the institution’s academic mission. In his position as Vice-president for Interventional Services, he has provided professional leadership and oversight for our surgical and interventional operation which encompasses a large number of clinical venues and departments. A particular focus has been personnel and facility upgrades for a multi-disciplinary effort in vascular interventions that ensure that Cedars-Sinai is a national leader. This initiative incorporates vascular surgery, cardiology, neuroendovascular and peripheral interventions.